Antibodies targeted to TRAIL receptor-2 and ErbB-2 synergize in vivo and induce an antitumor immune response
John Stagg, Janelle Sharkey, Sandra Pommey, Richard Young, Kazuyoshi Takeda, Hideo Yagita, Ricky W Johnstone, Mark J Smyth
Proceedings of the National Academy of Sciences | NATL ACAD SCIENCES | Published : 2008
This work was supported by a Susan G. Komen for the Cure Grant. J. Stagg is supported by a Canadian Institutes of Health Research Fellowship. R.W.J. is a Pfizer Australia Research Fellow and is supported by a National Health and Medical Research Council of Australia Program Grant, the Cancer Council Victoria, and the Leukemia Foundation of Australia. M.J.S. is supported by a National Health and Medical Research Council Australia Research Fellowship and Program Grant.